CureVac

Where are they now? 4 biotechs that soared then crashed during the pandemic
Pharma Voice
Fri, 11/15/24 - 11:06 am
biotech
pandemic
COVID-19
CureVac
Novavax
Inovio
Veru
Pfizer, BioNTech win bid to invalidate CureVac's UK COVID vaccine patents
Reuters
Tue, 10/8/24 - 10:13 am
Pfizer
BioNTech
CureVac
patents
COVID-19
vaccines
legal
GSK Pays $430M Upfront for CureVac’s COVID-19, Flu mRNA Vaccines
BioSpace
Wed, 07/3/24 - 11:25 am
GSK
CureVac
MRNA
COVID-19
Flu
vaccines
Bird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks
Yahoo/Bloomberg
Fri, 05/24/24 - 11:16 am
vaccines
CureVac
Moderna Therapeutics
H5N1
CureVac initiates H5N1 avian influenza vaccine study
Clinical Trials Arena
Thu, 04/25/24 - 11:35 am
CureVac
GSK
vaccines
H5N1
clinical trials
CureVac to cut costs in restructuring
BioPharma Dive
Wed, 04/24/24 - 09:14 pm
CureVac
vaccines
layoffs
CureVac, chasing Moderna's mRNA flu vaccine, runs into the same B strain problems
Fierce Biotech
Thu, 04/4/24 - 11:24 am
CureVac
Moderna Therapeutics
MRNA
flu vaccine
Flu
influenza B
vaccines
CureVac touts 'progress' as German court suspends infringement proceedings against BioNTech
Fierce Pharma
Thu, 09/28/23 - 11:40 pm
CureVac
BioNTech
MRNA
patents
legal
CureVac’s COVID vaccine patent battle with Pfizer, BioNTech heads South
Medical Marketing and Media
Fri, 05/19/23 - 10:22 am
CureVac
COVID-19
vaccines
Pfizer
BioNTech
patents legal
Orbital shows 2023’s venture funding scene is far from stratospheric
EP Vantage
Fri, 05/19/23 - 10:06 am
RNA
funding
venture capital
Altos Labs
CureVac
EQRx
Hasten Biopharmaceutic
Orbital Therapeutics
Sana Biotechnology
Suzhou Abogen Biosciences
TORL BioTherapeutics
GSK, CureVac initiate new Phase I/II trial of mRNA flu vaccine
Clinical Trials Arena
Mon, 05/8/23 - 11:27 pm
GSK
CureVac
vaccines
MRNA
Flu
After 'half-baked' data drop, CureVac releases results on mRNA flu, COVID-19 vaccines in older adults
Fierce Biotech
Mon, 01/30/23 - 10:33 am
CureVac
clinical trials
MRNA
vaccines
COVID-19
Flu
GSK
CureVac's 'half-baked' COVID-flu data release questioned by analysts, but shares still rally 17%
Fierce Biotech
Sun, 01/8/23 - 10:05 pm
CureVac
GSK
MRNA
vaccines
COVID-19
clinical trials
CureVac rethinks lead cancer program after posting PD-1 data, limiting future studies to mRNA vaccine combos
Fierce Biotech
Wed, 11/16/22 - 10:35 am
CureVac
vaccines
CV8102
MRNA
cancer
Few safe havens surface in another down quarter for biopharma
EP Vantage
Fri, 10/14/22 - 10:03 am
biopharma stocks
COVID-19
Eli Lilly
Bristol Myers Squibb
Merck
Daiichi Sankyo
Vertex Pharmaceuticals
Takeda
Neurocrine
Sarepta Therapeutics
Orion
Pfizer
GSK
Roche
Moderna Therapeutics
BeiGene
BioNTech
Novavax
CureVac
CureVac begins Phase I Omicron-targeting Covid-19 vaccine trial
Clinical Trials Arena
Fri, 08/19/22 - 10:31 am
CureVac
clinical trials
MRNA
CV0501
boosters
COVID-19
Pfizer and BioNTech Push Hard on Omicron-Specific Vaccine While Fending Off Lawsuits
BioSpace
Wed, 07/27/22 - 10:47 am
Pfizer
BioNTech
COVID-19
vaccines
boosters
patents
CureVac
Pfizer, BioNTech rebuff CureVac's 'groundless' patent infringement claims against COVID-19 shot Comirnaty
Fierce Pharma
Tue, 07/26/22 - 11:23 am
Pfizer
BioNTech
COVID-19
CureVac
vaccines
patents
After its own vaccine flop, CureVac sues Pfizer partner BioNTech for patent infringement
Fierce Pharma
Tue, 07/5/22 - 10:46 am
COVID-19
CureVac
BioNTech
patents
vaccines
CureVac increases focus on cancer vaccine development
Biopharma Reporter
Mon, 05/30/22 - 10:17 am
CureVac
myNEO
vaccines
cancer
MRNA

Pages